Ensysce Biosciences, Inc.
ENSCNasdaqCIK 1716947HealthcareFiscal year ends Dec 31
Reports and events: 209 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-1621:56 ET | 8-K/A | 9.01 Financial statements and exhibits | 0001493152-26-047317 |
| 2026-09-2908:31 ET | 8-K | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001493152-26-044802 |
| 2026-08-2517:12 ET | 8-K | 8.01 Other events | 0001493152-26-040080 |
| 2026-08-2417:13 ET | 8-K | 8.01 Other events | 0001493152-26-039898 |
| 2026-08-1812:30 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001493152-26-038943 |
| 2026-08-1316:31 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001493152-26-037817 |
| 2026-08-1316:20 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-26-037794 |
| 2026-08-0615:45 ET | 8-K/A | 9.01 Financial statements and exhibits | 0001493152-26-036326 |
| 2026-08-0608:20 ET | 8-K | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 3.02 Unregistered sale of equity; 3.03 Change to security holders’ rights; 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-036268 |
| 2026-07-1516:15 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-26-033360 |
| 2026-05-2216:55 ET | 8-K | 3.01 Delisting notice | 0001493152-26-025061 |
| 2026-05-1516:20 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001493152-26-023811 |
| 2026-05-1516:20 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-26-023810 |
| 2026-04-0821:05 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-015602 |
| 2026-04-0316:14 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-26-015139 |
| 2026-03-3017:38 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001493152-26-013633 |
| 2026-03-3017:37 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-26-013622 |
| 2026-03-3017:47 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-26-013314 |
| 2026-03-2308:00 ET | 8-K | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001493152-26-012062 |
| 2026-02-2716:30 ET | 8-K | 3.01 Delisting notice | 0001493152-26-008343 |
| 2026-01-0817:14 ET | 8-K | 5.07 Shareholder vote results | 0001493152-26-000994 |
| 2025-12-0213:26 ET | DEF 14A | Proxy statementPeriod 2025-12-02 | 0001493152-25-025696 |
| 2025-11-1717:29 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-25-023933 |
| 2025-11-1416:16 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001493152-25-023498 |
| 2025-11-1416:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-25-023492 |
| 2025-08-1316:30 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001641172-25-023512 |
| 2025-08-1316:20 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001641172-25-023500 |
| 2025-06-0517:02 ET | 8-K | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001641172-25-013853 |
| 2025-05-1316:20 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001641172-25-009955 |
| 2025-05-1316:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001641172-25-009949 |
| 2025-04-2416:27 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001641172-25-006009 |
| 2025-04-0116:30 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001641172-25-002087 |
| 2025-03-3116:20 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001641172-25-001751 |
| 2025-03-1016:20 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001493152-25-009703 |
| 2025-03-1016:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-25-009695 |
| 2025-02-0417:29 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001493152-25-004880 |
| 2024-12-0316:15 ET | 8-K | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001493152-24-048497 |
| 2024-11-2116:15 ET | 8-K | 5.07 Shareholder vote results | 0001493152-24-047149 |
| 2024-11-1216:20 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001493152-24-044768 |
| 2024-11-1216:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-24-044760 |
| 2024-10-1816:56 ET | 8-K | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001493152-24-041589 |
| 2024-10-1821:34 ET | DEF 14A | Proxy statementPeriod 2024-10-17 | 0001493152-24-041470 |
| 2024-08-3020:54 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-24-034451 |
| 2024-08-2316:30 ET | 8-K | 3.01 Delisting notice | 0001493152-24-033731 |
| 2024-08-1416:32 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-24-032272 |
| 2024-08-1416:30 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001493152-24-032263 |
| 2024-05-2808:10 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-24-021456 |
| 2024-05-1308:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-24-018793 |
| 2024-05-1318:08 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001493152-24-018718 |
| 2024-05-0916:40 ET | 8-K | 8.01 Other events | 0001493152-24-018482 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 30, 2026, 17:37 ET. Listed shows no prices and gives no investment advice.